PACK: 2.5mg (10 pills)
Femrpo, containing the active ingredient letrozole is considered a non-steroid type aromatase inhibitor. It works by preventing the aromatase enzyme from converting androstenedione and testosterone into estrogen. It can be used to treat and prevent breast cancer in postmenopausal women, slowing the growth of some types of breast tumors that require estrogen for growth.
Fempro (letrozole) is used to treat breast cancer in postmenopausal women, i.e. In whom there is no menstruation due to age or after surgery or chemotherapy. Fempro (letrozole) is available in the form of tablets containing 2.5 mg of active substance letrozola. Letrozole belongs to a group of substances called “aromatase inhibitors”. They are also called “anti-estrogens”, as they reduce the production of estrogen in the body.
Estrogen promotes the development of certain types of breast cancer, which are called hormone-dependent. Reducing the production of this hormone can prevent the growth of the tumor. This drug is suitable for patients who use for the first time an antiestrogenic drug and those who have already had experience using other similar drugs, such as Tamoxifen.
If you have any questions about the reasons for prescribing Fempro (Letrozole), consult your doctor. You may have been prescribed a drug for reasons not described above.
The recommended dose of the drug Fempro (letrozole) is one tablet once a day. Tablets are taken orally, with a glass of water or other liquid. If after taking the pill you will notice an upset stomach, take it with or after eating.